JPH08500096A - (3r,4r)−δ▲上6▼−テトラヒドロカンナビノール−7−酸 - Google Patents
(3r,4r)−δ▲上6▼−テトラヒドロカンナビノール−7−酸Info
- Publication number
- JPH08500096A JPH08500096A JP6503574A JP50357494A JPH08500096A JP H08500096 A JPH08500096 A JP H08500096A JP 6503574 A JP6503574 A JP 6503574A JP 50357494 A JP50357494 A JP 50357494A JP H08500096 A JPH08500096 A JP H08500096A
- Authority
- JP
- Japan
- Prior art keywords
- mammal
- administering
- effective amount
- compound
- pharmaceutical composition
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
- C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D311/78—Ring systems having three or more relevant rings
- C07D311/80—Dibenzopyrans; Hydrogenated dibenzopyrans
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pain & Pain Management (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Rheumatology (AREA)
- Biomedical Technology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Saccharide Compounds (AREA)
- Fats And Perfumes (AREA)
- Tires In General (AREA)
- Glass Compositions (AREA)
- Pyrane Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
Description
Claims (1)
- 【特許請求の範囲】 1. 式 で、式中のR1が、水素原子、−COCH3あるいは−COCH2CH3であり、R2 が、必要に応じて末端芳香環を有する直鎖あるいは枝分かれC5−C12アルキル ;−(CH2)m−O−R3で、式中のmが0−7の整数、そしてR3が、必要に応 じて末端芳香環を有する、1−12個の炭素原子を含む直鎖あるいは枝分かれの アルキルである基;またはCH−(CH3)−(CH2)n−O−R4で、式中のn が0−7の整数、そしてR4’が、必要に応じて末端芳香環を有する、1−12 個の炭素原子を含む直鎖あるいは枝分かれのアルキルである基である化合物。 2. R1が水素であり、R2が、1、1−ジメチルヘプチルである請求の範囲第 1項に記載の化合物。 3. R1が−COCH3であり、R2が、1,1−ジメチルヘプチルである請求 の範囲第1項に記載の化合物。 4. 請求の範囲第1項に記載の化合物を含有する製剤組成物。 5. 請求の範囲第2項に記載の化合物を含有する製剤組成物。 6. 請求の範囲第3項に記載の化合物を含有する製剤組成物。 7. 哺乳動物の痛みを緩和するにあたって、その動物に、鎮痛有効量の請求の 範囲第1項に記載の化合物を投与する方法。 8. 哺乳動物の痛みを緩和するにあたって、その動物に、鎮痛有効量の請求の 範囲第4項に記載の製剤組成物を投与する方法。 9. 哺乳動物の痛みを緩和するにあたって、その動物に、鎮痛有効量の請求の 範囲第2項に記載の化合物を投与する方法。 10.哺乳動物の痛みを緩和するにあたって、その動物に、鎮痛有効量の請求の 範囲第5項に記載の製剤組成物を投与する方法。 11.哺乳動物の痛みを緩和するにあたって、その動物に、鎮痛有効量の請求の 範囲第3項に記載の化合物を投与する方法。 12.哺乳動物の痛みを緩和するにあたって、その動物に、鎮痛有効量の請求の 範囲第6項に記載の製剤組成物を投与する方法。 13. 哺乳動物の生体組織の炎症を緩和するにあたって、その動物に、抗炎症 有効量の請求の範囲第1項に記載の化合物を投与する方法。 14. 哺乳動物の生体組織の炎症を緩和するにあたって、その動物に、抗炎症 有効量の請求の範囲第4項に記載の製剤組成物を投与する方法。 15. 哺乳動物の生体組織の炎症を緩和するにあたって、その動物に、抗炎症 有効量の請求の範囲第2項に記載の化合物を投与する方法。 16. 哺乳動物の生体組織の炎症を緩和するにあたって、その動物に、抗炎症 有効量の請求の範囲第5項に記載の製剤組成物を投与する方法。 17. 哺乳動物の生体組織の炎症を緩和するにあたって、その動物に、抗炎症 有効量の請求の範囲第3項に記載の化合物を投与する方法。 18. 哺乳動物の生体組織の炎症を緩和するにあたって、その動物に、抗炎症 有効量の請求の範囲第6項に記載の製剤組成物を投与する方法。
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US913,096 | 1992-07-14 | ||
| US07/913,096 US5338753A (en) | 1992-07-14 | 1992-07-14 | (3R,4R)-Δ6 -tetrahydrocannabinol-7-oic acids useful as antiinflammatory agents and analgesics |
| PCT/US1993/006580 WO1994001429A1 (en) | 1992-07-14 | 1993-07-13 | (3r,4r)-δ6-tetrahydrocannabinol-7-oic acids |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JPH08500096A true JPH08500096A (ja) | 1996-01-09 |
| JP3278159B2 JP3278159B2 (ja) | 2002-04-30 |
Family
ID=25432922
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP50357494A Expired - Fee Related JP3278159B2 (ja) | 1992-07-14 | 1993-07-13 | (3r,4r)−δ▲上6▼−テトラヒドロカンナビノール−7−酸 |
Country Status (12)
| Country | Link |
|---|---|
| US (1) | US5338753A (ja) |
| EP (1) | EP0650483B1 (ja) |
| JP (1) | JP3278159B2 (ja) |
| KR (1) | KR100289202B1 (ja) |
| AT (1) | ATE183744T1 (ja) |
| AU (1) | AU676845B2 (ja) |
| CA (1) | CA2140368C (ja) |
| DE (1) | DE69326149T2 (ja) |
| DK (1) | DK0650483T3 (ja) |
| ES (1) | ES2138626T3 (ja) |
| GR (1) | GR3031966T3 (ja) |
| WO (1) | WO1994001429A1 (ja) |
Families Citing this family (51)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5635530A (en) * | 1991-09-12 | 1997-06-03 | Yissum Research Development Company Of The Hebrew University Of Jerusalem | (3S,4S)-delta-6-tetrahydrocannabinol-7-oic acids and derivatives thereof, processors for their preparation and pharmaceutical compositions containing them |
| IL115245A (en) * | 1995-09-11 | 2002-12-01 | Yissum Res Dev Co | Tumor necrosis factor inhibiting pharmaceuticals |
| US6132762A (en) * | 1997-05-05 | 2000-10-17 | Cristobal; Walter | Transcutaneous application of marijuana |
| US6162829A (en) * | 1997-10-17 | 2000-12-19 | Atlantic Pharmaceuticals, Inc. | (3R,4R)-Δ8 -tetrahydrocannabinol-11-oic acids useful as antiinflammatory agents and analgesics |
| GB9807639D0 (en) | 1998-04-14 | 1998-06-10 | Kennedy Rheumatology Inst | Anti-inflammatory agents |
| US5847128A (en) * | 1998-05-29 | 1998-12-08 | Virginia Commonwealth University | Water soluble derivatives of cannabinoids |
| US6566560B2 (en) | 1999-03-22 | 2003-05-20 | Immugen Pharmaceuticals, Inc. | Resorcinolic compounds |
| CN1377261A (zh) | 1999-03-22 | 2002-10-30 | 免疫力药品有限公司 | 治疗免疫疾病 |
| US6448288B1 (en) * | 2000-05-17 | 2002-09-10 | University Of Massachusetts | Cannabinoid drugs |
| AU2001296402A1 (en) * | 2000-09-28 | 2002-04-08 | Immugen Pharmaceuticals, Inc. | Methods and compounds for inhibiting eicosanoid metabolism and platelet aggregation |
| US6541510B2 (en) * | 2000-09-28 | 2003-04-01 | Immugen Pharmaceuticals, Inc. | Antiviral methods and compounds |
| US7507767B2 (en) * | 2001-02-08 | 2009-03-24 | Schering Corporation | Cannabinoid receptor ligands |
| US7067539B2 (en) * | 2001-02-08 | 2006-06-27 | Schering Corporation | Cannabinoid receptor ligands |
| WO2003007876A2 (en) * | 2001-06-25 | 2003-01-30 | University Of Massachusetts | N-fatty acid-amino acid conjugates and therapeutic uses |
| CA2450073C (en) | 2001-07-25 | 2017-08-29 | Biomarin Pharmaceutical Inc. | Compositions and methods for modulating blood-brain barrier transport |
| AR037352A1 (es) * | 2001-11-14 | 2004-11-03 | Schering Corp | Compuestos ligandos de los receptores de los cannabinoides, una composicion farmaceutica , y el uso de dichos compuestos para la manufactura de medicamentos |
| WO2003070277A1 (en) | 2002-02-19 | 2003-08-28 | Shionogi & Co., Ltd. | Antipruritics |
| WO2003080043A1 (en) * | 2002-03-18 | 2003-10-02 | Immugen Pharmaceuticals, Inc. | Topical formulations of resorcinols and cannibinoids and methods of use |
| EP1539693B9 (en) | 2002-06-19 | 2008-10-08 | Schering Corporation | Cannabinoid receptor agonists |
| DE60328033D1 (de) | 2002-11-25 | 2009-07-30 | Schering Corp | Cannabinoid-rezeptorliganden |
| WO2004058251A1 (en) * | 2002-12-19 | 2004-07-15 | University Of Massachusetts | Cannabinoid analogs as peroxisome proliferator activated nuclear receptor gamma activators |
| TW200505902A (en) * | 2003-03-20 | 2005-02-16 | Schering Corp | Cannabinoid receptor ligands |
| US6916852B2 (en) * | 2003-05-12 | 2005-07-12 | University Of Tennessee Research Foundation | Method for regulation of microvascular tone |
| US20050070596A1 (en) * | 2003-05-12 | 2005-03-31 | David Baker | Methods for treatment of inflammatory diseases using CT-3 or analogs thereof |
| WO2005019811A2 (en) * | 2003-08-26 | 2005-03-03 | Blueshift Biotechnologies, Inc. | Time dependent fluorescence measurements |
| US20050264805A1 (en) * | 2004-02-09 | 2005-12-01 | Blueshift Biotechnologies, Inc. | Methods and apparatus for scanning small sample volumes |
| WO2006002133A1 (en) * | 2004-06-22 | 2006-01-05 | Schering Corporation | Cannabinoid receptor ligands |
| US7141378B2 (en) | 2004-07-02 | 2006-11-28 | Blueshift Biotechnologies, Inc. | Exploring fluorophore microenvironments |
| US7544714B2 (en) * | 2004-07-16 | 2009-06-09 | University Of Massachusetts | Lipid-amino acid conjugates and methods of use |
| WO2006065792A2 (en) * | 2004-12-13 | 2006-06-22 | Indevus Pharmaceuticals, Inc. | Treatment of interstitial cystitis using cannabinoid analogs |
| WO2006065793A2 (en) * | 2004-12-13 | 2006-06-22 | Indevus Pharmaceuticals, Inc. | TREATMENT OF INTERSTITIAL CYSTITIS USING (6aR,10aR)-Δ8-TETRAHYDROCANNABINOL-11-OIC ACIDS |
| EP2671508B1 (en) | 2005-04-28 | 2020-09-16 | Proteus Digital Health, Inc. | Pharma-informatics system |
| TWI366460B (en) | 2005-06-16 | 2012-06-21 | Euro Celtique Sa | Cannabinoid active pharmaceutical ingredient for improved dosage forms |
| US20070037873A1 (en) * | 2005-08-08 | 2007-02-15 | Zurier Robert B | Airway remodeling treatments |
| EP2578561A1 (en) * | 2005-09-29 | 2013-04-10 | Albany Molecular Research, Inc. | Processes for the production of cannabidiol derivatives and intermediates thereof |
| US20070093519A1 (en) * | 2005-10-20 | 2007-04-26 | Indevus Pharmaceuticals, Inc. | Anti-emetic uses of cannabinoid analogs |
| US20070099988A1 (en) * | 2005-10-31 | 2007-05-03 | Indevus Pharmaceuticals, Inc. | Anti-emetic uses of (3r, 4r)-delta8-tetrahydrocannabinol-11-oic acids |
| JP2010503710A (ja) | 2006-09-18 | 2010-02-04 | ラプトール ファーマシューティカル インコーポレイテッド | 受容体関連タンパク質(rap)結合体の投与による肝障害の処置 |
| ES2919563T3 (es) | 2009-02-20 | 2022-07-27 | Enhanx Biopharm Inc | Sistema de administración de medicamentos a base de glutatión |
| KR20180114970A (ko) | 2009-05-06 | 2018-10-19 | 라보라토리 스킨 케어, 인크. | 활성제-칼슘 포스페이트 입자 복합체를 포함하는 피부 전달 조성물 및 이들을 이용하는 방법 |
| US9066910B2 (en) * | 2010-04-15 | 2015-06-30 | Steven Rosenblatt | Methods and compositions of cannabis extracts |
| US20120077778A1 (en) | 2010-09-29 | 2012-03-29 | Andrea Bourdelais | Ladder-Frame Polyether Conjugates |
| KR20160002709A (ko) | 2013-02-12 | 2016-01-08 | 코버스 파마수티컬스, 아이엔씨. | 초고순도 테트라하이드로카나비놀-11-오익산 |
| US9585867B2 (en) | 2015-08-06 | 2017-03-07 | Charles Everett Ankner | Cannabinod formulation for the sedation of a human or animal |
| US20170038184A1 (en) | 2015-08-06 | 2017-02-09 | Charles E. Ankner | Formulation delivery system |
| US10239808B1 (en) | 2016-12-07 | 2019-03-26 | Canopy Holdings, LLC | Cannabis extracts |
| US11202771B2 (en) | 2018-01-31 | 2021-12-21 | Treehouse Biotech, Inc. | Hemp powder |
| EP3864000A4 (en) | 2018-10-10 | 2022-08-10 | Treehouse Biosciences, Inc. | CANNABIGEROL SYNTHESIS |
| MX2022002183A (es) | 2019-08-22 | 2022-05-24 | Epm Group Inc | Composiciones de éster de ácido cannabinoide y sus usos. |
| WO2021072325A1 (en) * | 2019-10-11 | 2021-04-15 | Corbus Pharmaceuticals, Inc. | Compositions of ajulemic acid and uses thereof |
| US12029718B2 (en) | 2021-11-09 | 2024-07-09 | Cct Sciences, Llc | Process for production of essentially pure delta-9-tetrahydrocannabinol |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4973603A (en) * | 1988-06-16 | 1990-11-27 | Sumner Burstein | Platelet activating factor antagonist and methods of use therefor |
| IL99468A (en) * | 1991-09-12 | 1997-09-30 | Yissum Res Dev Co | (3s, 4s)-delta- 6-tetrahydrocannabinol- 7-oic acids and derivatives thereof, processes for their preparation and pharmaceutical compositions containing them |
-
1992
- 1992-07-14 US US07/913,096 patent/US5338753A/en not_active Expired - Lifetime
-
1993
- 1993-07-13 EP EP93917149A patent/EP0650483B1/en not_active Expired - Lifetime
- 1993-07-13 CA CA002140368A patent/CA2140368C/en not_active Expired - Fee Related
- 1993-07-13 WO PCT/US1993/006580 patent/WO1994001429A1/en not_active Ceased
- 1993-07-13 DK DK93917149T patent/DK0650483T3/da active
- 1993-07-13 KR KR1019950700133A patent/KR100289202B1/ko not_active Expired - Fee Related
- 1993-07-13 AT AT93917149T patent/ATE183744T1/de not_active IP Right Cessation
- 1993-07-13 JP JP50357494A patent/JP3278159B2/ja not_active Expired - Fee Related
- 1993-07-13 AU AU46759/93A patent/AU676845B2/en not_active Ceased
- 1993-07-13 DE DE69326149T patent/DE69326149T2/de not_active Expired - Fee Related
- 1993-07-13 ES ES93917149T patent/ES2138626T3/es not_active Expired - Lifetime
-
1999
- 1999-11-25 GR GR990403059T patent/GR3031966T3/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| WO1994001429A1 (en) | 1994-01-20 |
| EP0650483B1 (en) | 1999-08-25 |
| KR100289202B1 (ko) | 2001-05-02 |
| EP0650483A4 (en) | 1995-05-10 |
| ES2138626T3 (es) | 2000-01-16 |
| HK1010690A1 (en) | 1999-06-25 |
| KR950702549A (ko) | 1995-07-29 |
| AU4675993A (en) | 1994-01-31 |
| CA2140368A1 (en) | 1994-01-20 |
| AU676845B2 (en) | 1997-03-27 |
| EP0650483A1 (en) | 1995-05-03 |
| GR3031966T3 (en) | 2000-03-31 |
| ATE183744T1 (de) | 1999-09-15 |
| DE69326149D1 (de) | 1999-09-30 |
| DK0650483T3 (da) | 2000-03-27 |
| JP3278159B2 (ja) | 2002-04-30 |
| US5338753A (en) | 1994-08-16 |
| CA2140368C (en) | 2004-04-27 |
| DE69326149T2 (de) | 2000-04-27 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP3278159B2 (ja) | (3r,4r)−δ▲上6▼−テトラヒドロカンナビノール−7−酸 | |
| US6355650B1 (en) | (3R,4R)-Δ8-tetrahydrocannabinol-11-oic acids useful as antiinflammatory agents and analgesics | |
| AU778149B2 (en) | Agonists specific for the peripheral cannabinoid receptor | |
| JP2004503498A (ja) | カンナビジオール誘導体を含んでなる医薬組成物 | |
| CN105517989A (zh) | 大麻素类化合物的混合物及其制备和用途 | |
| JPH0381248A (ja) | キノン誘導体 | |
| WO2003063758A2 (en) | Bicyclic cb2 cannabinoid receptor ligands | |
| US20050020544A1 (en) | Bicyclic CB2 cannabinoid receptor ligands | |
| JPS6383045A (ja) | アミド置換ナフタレン類及びその中間体 | |
| AU2006253734A1 (en) | Benzofuran derivatives with therapeutic activities | |
| JPH0748255A (ja) | ピリミドン誘導体及び類似化合物を含有する、喘息又は炎症性気道疾患の治療用医薬組成物 | |
| AU2003209616A1 (en) | Bicyclic CB2 cannabinoid receptor ligands | |
| JPS6150977A (ja) | 新規な縮合ベンズ(チオ)アミド、それらの製造方法およびそれらを有効成分として含有する薬剤 | |
| JP3298881B2 (ja) | (3s,4s)−デルタ−6−テトラヒドロカンナビノール−7−酸及びそれらの誘導体並びにそれらの合成方法並びにそれらを含む医薬組成物 | |
| Mechoulam et al. | Cannabinoids in models of chronic inflammatory conditions | |
| US20070105946A1 (en) | Tocopherol derivatives with a long hydroxylated chain, which can be used as neurotrophics | |
| JPH0940597A (ja) | シナモフィリン及びその誘導体とこれらの製造方法及び血小板凝集抑制薬剤、気管弛緩薬剤、酸化防止剤及び血管弛緩薬剤 | |
| HK1010690B (en) | (3r, 4r)-△- tetrahydrocannabinol-7-oic acids | |
| US4098799A (en) | 3-formylchromones | |
| JP2721178B2 (ja) | フェノール誘導体 | |
| PL120366B1 (en) | Process for preparing novel benzocycloheptapyranes | |
| HK1029925B (en) | Cannabinol-11-oic acid derivatives useful as antiinflammatory agents and analgesics | |
| CN106380400A (zh) | 一种萜品烯醇类化合物及其制备方法和应用 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20080215 Year of fee payment: 6 |
|
| FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20090215 Year of fee payment: 7 |
|
| FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20090215 Year of fee payment: 7 |
|
| FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20090215 Year of fee payment: 7 |
|
| FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20090215 Year of fee payment: 7 |
|
| FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20090215 Year of fee payment: 7 |
|
| FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20100215 Year of fee payment: 8 |
|
| LAPS | Cancellation because of no payment of annual fees |